𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of GF120918, a Potent P-glycoprotein Inhibitor, on Morphine Pharmacokinetics and Pharmacodynamics in the Rat

✍ Scribed by Stephen P. Letrent; Gary M. Pollack; Kenneth R. Brouwer; Kim L. R. Brouwer

Book ID
110307581
Publisher
Springer US
Year
1998
Tongue
English
Weight
582 KB
Volume
15
Category
Article
ISSN
0724-8741

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Oxycodone pharmacokinetics and pharmacod
Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833
✍ Emma BostrΓΆm; Ulrika S.H. Simonsson; Margareta Hammarlund-Udenaes πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 93 KB

The objective of this study was to investigate the in vivo influence of the P-glycoprotein (P-gp) inhibitor PSC833 on the plasma pharmacokinetics, total brain concentrations and tail-flick latency of oxycodone in rats. Eight rats each received an infusion of PSC833 or vehicle without PSC833. One hou

Pharmacokinetics and pharmacodynamics of
Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine
✍ Marianne Ekblom; Marie GΓ₯rdmark; Margareta Hammarlund-Udenaes πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 555 KB

In this study the pharmacokinetics and pharmacodynamics of morphine-3-glucuronide (M3G) were investigated in rats after i.v. administration as a bolus dose (86.7 pmol kg-I) and as a constant rate infusion (2.9 pmol h-') over 5 days. After the bolus dose, the clearance (Cl) was 12.1 ~0.6mlmin-\*\*kg,